Whanin Pharmaceutical Q3 Operating Profit Rises 111.8%
Whanin Pharmaceutical reported consolidated operating profit of 7.53십억원 in Q3 2026, up 111.8% year over year. Revenue was 71.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.